Amedeo Smart

Free Medical Literature Service



Obstructive Lung Diseases

  Free Subscription

Articles published in
Respir Med
    August 2021
  1. AL-AHMAD M, Nurkic J, Othman Y, Jusufovic E, et al
    Severe asthma in Kuwait population: Phenotype-based approach.
    Respir Med. 2021;187:106586.
    >> Share

  2. CAPSTICK TG, Azeez NF, Deakin G, Goddard A, et al
    Ward based inhaler technique service reduces exacerbations of asthma and COPD.
    Respir Med. 2021;187:106583.
    >> Share

  3. GAGNE M, Lam Shin Cheung J, Kouri A, FitzGerald JM, et al
    A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm.
    Respir Med. 2021 Aug 10:106568. doi: 10.1016/j.rmed.2021.106568.
    >> Share

  4. SCHNEIDER CV, Strnad P
    SARS-CoV-2 infection in alpha1-antitrypsin deficiency.
    Respir Med. 2021;184:106466.
    >> Share

    July 2021
  5. WU J, Bracken J, Lam A, Francis KL, et al
    Refining diagnostic criteria for paediatric bronchiectasis using low-dose CT scan.
    Respir Med. 2021;187:106547.
    >> Share

  6. WAATEVIK M, Frisk B, Real FG, Hardie JA, et al
    CT-defined emphysema in COPD patients and risk for change in desaturation status in 6-min walk test.
    Respir Med. 2021;187:106542.
    >> Share

  7. VEDEL-KROGH S, Nielsen SF, Nordestgaard BG, Lange P, et al
    Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Respir Med. 2021;186:106529.
    >> Share

    June 2021
  8. THI LAM H, Van Tuong N, Sy DQ, Lundback B, et al
    Bronchial hyperresponsiveness is common in Hanoi, Vietnam: Asthma probably underdiagnosed.
    Respir Med. 2021;186:106513.
    >> Share

  9. ZHANG M, Jin M, Zhou X, Lin J, et al
    Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China.
    Respir Med. 2021;186:106522.
    >> Share

  10. CHAPMAN KR, An L, Bosnic-Anticevich S, Campomanes CM, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Respir Med. 2021;186:106524.
    >> Share

  11. SCHYLLERT C, Andersson M, Backman H, Lindberg A, et al
    Childhood onset asthma is associated with lower educational level in young adults - A prospective cohort study.
    Respir Med. 2021;186:106514.
    >> Share

  12. YOUSIF A, Forget A, Beauchesne MF, Lemiere C, et al
    Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
    Respir Med. 2021;185:106510.
    >> Share

  13. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    >> Share

  14. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    >> Share

  15. JEONG JH, Heo M, Kim EJ, Hah YS, et al
    Serum hepatocyte growth factor as a predictor of disease severity and future exacerbations in patients with non-cystic fibrosis bronchiectasis.
    Respir Med. 2021;185:106505.
    >> Share

  16. GARCIA-PACHON E, Ruiz-Alcaraz S, Baeza-Martinez C, Zamora-Molina L, et al
    Symptoms in patients with asthma infected by SARS-CoV-2.
    Respir Med. 2021;185:106495.
    >> Share

  17. SHKEIRI R, Saliba W, Stein N, Najjar R, et al
    Exploring factors associated with acquisition and chronicity of infection in bronchiectasis: A population-based study.
    Respir Med. 2021;185:106487.
    >> Share

  18. SADEGHDOUST M, Mirsadraee M, Aligolighasemabadi F, Khakzad MR, et al
    Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial.
    Respir Med. 2021;185:106494.
    >> Share

  19. MANISCALCO M, Ambrosino P, Fuschillo S, Stufano S, et al
    Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation.
    Respir Med. 2021;182:106401.
    >> Share

  20. CRIMI C, Campisi R, Nolasco S, Cacopardo G, et al
    Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
    Respir Med. 2021;185:106491.
    >> Share

    May 2021
  21. ANDUJAR-ESPINOSA R, Aparicio-Vicente M, Ruiz-Lopez FJ, Salinero-Gonzalez L, et al
    Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.
    Respir Med. 2021;185:106484.
    >> Share

  22. LISSPERS K, Stallberg B, Larsson K, Janson C, et al
    Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients' data using machine learning - Based on the ARCTIC study.
    Respir Med. 2021;185:106483.
    >> Share

    March 2021
  23. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    >> Share

  24. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    >> Share

  25. SAFAVI S, Munidasa S, Zanette B, Dai R, et al
    Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
    Respir Med. 2021;180:106368.
    >> Share

  26. LEE JM, Lee SA, Han CH, Lee SM, et al
    Body mass index as a predictor of mortality in bronchiectasis: A nationwide population-based study.
    Respir Med. 2021;180:106370.
    >> Share

  27. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.
    >> Share

  28. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    >> Share

    February 2021
  29. HAN DW, Jo KW, Kim OH, Shim TS, et al
    Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Respir Med. 2021;179:106340.
    >> Share

  30. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    >> Share

    January 2021
  31. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    >> Share

  32. SOL IS, Jang H, Noh J, Kim SY, et al
    Mortality and morbidity in children with asthma: A nationwide study in Korea.
    Respir Med. 2021;177:106306.
    >> Share

  33. LIAO SY, Petrache I, Fingerlin TE, Maier LA, et al
    Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Respir Med. 2021;176:106275.
    >> Share

  34. CAZZOLA M, Ora J, Bianco A, Rogliani P, et al
    Guidance on nebulization during the current COVID-19 pandemic.
    Respir Med. 2021;176:106236.
    >> Share

  35. HOESTEREY D, Graham B, Tashkin DP, Barjaktarevic I, et al
    Mid-expiratory time as a potential spirometric index of early airflow obstruction.
    Respir Med. 2021;176:105977.
    >> Share

  36. BROWN LK, Miller A
    Spirometric indices of early airflow impairment in individuals at risk of developing COPD: Spirometry beyond FEV1/FVC.
    Respir Med. 2021;176:105921.
    >> Share

  37. BACKMAN BH, Virchow JC, Lundback B
    COPD in women - New results presented.
    Respir Med. 2021;176:106238.
    >> Share

    December 2020
  38. CHOATE R, Aksamit TR, Mannino D, Addrizzo-Harris D, et al
    Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study.
    Respir Med. 2020;177:106285.
    >> Share

  39. EGER K, Hashimoto S, Braunstahl GJ, Brinke AT, et al
    Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy.
    Respir Med. 2020;177:106287.
    >> Share

  40. SANGIOVANNI S, Morales EI, Fernandez-Trujillo L
    Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
    Respir Med. 2020;176:106283.
    >> Share

  41. LIU Y, Huang X, Chen D, Chen F, et al
    The detrimental qualitative and quantitative alterations of circulating endothelial progenitor cells in patients with bronchiectasis.
    Respir Med. 2020;176:106270.
    >> Share

    November 2020
  42. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    >> Share

  43. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    >> Share

  44. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    >> Share

  45. CAMINATI M, Vultaggio A, Matucci A, Senna G, et al
    Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
    Respir Med. 2020;176:106261.
    >> Share

  46. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    >> Share

  47. GAZOURIAN L, Thedinger WB, Regis SM, Pagura EJ, et al
    Qualitative emphysema and risk of COPD hospitalization in a multicenter CT lung cancer screening cohort study.
    Respir Med. 2020;176:106245.
    >> Share

  48. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    >> Share

  49. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    >> Share

  50. HUSSEIN MH, Toraih EA, Attia AS, Burley N, et al
    Asthma in COVID-19 patients: An extra chain fitting around the neck?
    Respir Med. 2020;175:106205.
    >> Share

  51. GRAFF S, Bricmont N, Moermans C, Henket M, et al
    Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Respir Med. 2020;175:106202.
    >> Share

  52. MOHR A, Plentz A, Sieroslawski A, Pezenburg F, et al
    Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
    Respir Med. 2020;174:106207.
    >> Share

  53. FEDDEMA JJ, Claassen E
    Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.
    Respir Med. 2020;173:106020.
    >> Share

  54. RAISANEN P, Hedman L, Andersson M, Stridsman C, et al
    Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.
    Respir Med. 2020;173:106017.
    >> Share

    October 2020
  55. QIN L, Li Z, Fan Y, Fang X, et al
    Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function.
    Respir Med. 2020;175:106208.
    >> Share

  56. PAOLETTI G, Keber E, Heffler E, Malipiero G, et al
    Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.
    Respir Med. 2020;174:106199.
    >> Share

  57. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Corrigendum to "Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority stu
    Respir Med. 2020 Oct 17:106186. doi: 10.1016/j.rmed.2020.106186.
    >> Share

  58. LITT HK, Press VG, Hull A, Siros M, et al
    Association between inhaler technique and confidence among hospitalized children with asthma.
    Respir Med. 2020;174:106191.
    >> Share

  59. MORILLO-VANEGAS D, Sanchez-Salcedo P, Sebastian Arino AF
    Relationship between pediatric asthma and psychosocial status of caregivers.
    Respir Med. 2020;174:106187.
    >> Share

    September 2020
  60. LASSMANN-KLEE PG, Piirila PL, Brumpton B, Larsson M, et al
    Parallel gradients in FENO and in the prevalences of asthma and atopy in adult general populations of Sweden, Finland and Estonia - A Nordic EpiLung study.
    Respir Med. 2020;173:106160.
    >> Share

  61. BUSBY J, Khoo E, Pfeffer PE, Mansur AH, et al
    The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
    Respir Med. 2020;173:106156.
    >> Share

  62. FOSTER JM, Beasley R, Braithwaite I, Harrison T, et al
    Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study.
    Respir Med. 2020;175:106154.
    >> Share

  63. BAGNASCO D, Brussino L, Bonavia M, Calzolari E, et al
    Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Respir Med. 2020;171:106080.
    >> Share

  64. FITZGERALD JM, Arnetorp S, Smare C, Gibson D, et al
    The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    Respir Med. 2020;171:106079.
    >> Share

  65. CHAN KPF, Ma TF, Kwok WC, Leung JKC, et al
    Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.
    Respir Med. 2020;171:106085.
    >> Share

    Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis.
    Respir Med. 2020;171:106096.
    >> Share

    August 2020
  67. WU TJ, Chen CH, Chen BY, Chin WS, et al
    Ambient air pollution and asthma onset in Taiwanese adults.
    Respir Med. 2020;172:106133.
    >> Share

  68. MARTINEZ-GARCIA MA, Posadas T, Sotgiu G, Blasi F, et al
    Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials.
    Respir Med. 2020;172:106127.
    >> Share

  69. KAHNERT K, Jorres RA, Kauczor HU, Biederer J, et al
    Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET.
    Respir Med. 2020;172:106117.
    >> Share

  70. LIANG Y, Wang D, Hua D, Liao H, et al
    Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.
    Respir Med. 2020;172:106126.
    >> Share

  71. DE NIJS SB, Krop EJM, Portengen L, Rijssenbeek-Nouwens LH, et al
    Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma.
    Respir Med. 2020;171:106123.
    >> Share

  72. IELPO A, Crisafulli E, Alcaraz-Serrano V, Gabarrus A, et al
    Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
    Respir Med. 2020;172:106090.
    >> Share

  73. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2020 Aug 5:106106. doi: 10.1016/j.rmed.2020.106106.
    >> Share

  74. PEEL AM, Wilkinson M, Sinha A, Loke YK, et al
    Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
    Respir Med. 2020;169:105984.
    >> Share

  75. SPRIO AE, Ciprandi G, Riccardi E, Giannoccaro F, et al
    The influence of smoking on asthma in the real-life.
    Respir Med. 2020;170:106066.
    >> Share

  76. MUKHOPADHYAY A, Waked M, Gogtay J, Gaur V, et al
    Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Respir Med. 2020;170:106055.
    >> Share

  77. HASAN SS, Capstick T, Zaidi STR, Kow CS, et al
    Use of corticosteroids in asthma and COPD patients with or without COVID-19.
    Respir Med. 2020;170:106045.
    >> Share

  78. OH JH, Ahn KM, Chung SJ, Shim JS, et al
    Usefulness of routine blood test-driven clusters for predicting acute exacerbation in patients with asthma.
    Respir Med. 2020;170:106042.
    >> Share

  79. BASLER L, Saxer S, Schneider SR, Lichtblau M, et al
    Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trial.
    Respir Med. 2020;170:106040.
    >> Share

  80. TSE SM
    Asthma-related hospitalizations following critical asthma in children: A comparison between Canada and the United States.
    Respir Med. 2020;170:106028.
    >> Share

  81. FOY BH, Natarajan S, Munawar A, Soares M, et al
    Characterising the role of small airways in severe asthma using low frequency forced oscillations: A combined computational and clinical approach.
    Respir Med. 2020;170:106022.
    >> Share

  82. GESSNER C, Kornmann O, Maspero J, van Zyl-Smit R, et al
    Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).
    Respir Med. 2020;170:106021.
    >> Share

  83. CRIMI C, Campisi R, Noto A, Genco S, et al
    Comparability of asthma control test scores between self and physician-administered test.
    Respir Med. 2020;170:106015.
    >> Share

  84. MEERBURG JJ, Veerman GDM, Aliberti S, Tiddens HAWM, et al
    Diagnosis and quantification of bronchiectasis using computed tomography or magnetic resonance imaging: A systematic review.
    Respir Med. 2020;170:105954.
    >> Share

  85. OUAALAYA EH, Falque L, Dupis JM, Sabatini M, et al
    Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
    Respir Med. 2020;169:106018.
    >> Share

  86. ARO M, Saaresranta T, Vahlberg T, Anttalainen U, et al
    Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy.
    Respir Med. 2020;169:106014.
    >> Share

    July 2020
  87. NG CACM, Knuiman MW, Murray K, Divitini ML, et al
    Childhood asthma increases respiratory morbidity, but not all-cause mortality in adulthood: The Busselton Health Study.
    Respir Med. 2020;171:106095.
    >> Share

  88. GARCIA-PACHON E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martinez C, et al
    Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.
    Respir Med. 2020;171:106084.
    >> Share

  89. POTT J, Krill A, Wilkens H, Bals R, et al
    Easy measurement of health related quality of life in patients with cystic fibrosis by the COPD assessment test (CAT) - A pilot study.
    Respir Med. 2020;168:105992.
    >> Share

  90. SHANKAR PS, Korukonda K, Bendre S, Behera D, et al
    Diagnoses and management of adult cough: An Indian Environmental Medical Association (EMA) position paper.
    Respir Med. 2020;168:105949.
    >> Share

    June 2020
  91. LIPPI G, Henry BM
    Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).
    Respir Med. 2020;167:105941.
    >> Share

  92. LEWIS A, Nolan CM, Man WDC, Kon SSC, et al
    Prognostication in COPD using physical function measures: Let's walk before we run away with conclusions.
    Respir Med. 2020;167:105942.
    >> Share

  93. JONES TPW, Brown J, Hurst JR, Vancheeswaran R, et al
    COPD exacerbation phenotypes in a real-world five year hospitalisation cohort.
    Respir Med. 2020;167:105979.
    >> Share

    May 2020
  94. ZAMARRON E, Romero D, Fernandez-Lahera J, Villasante C, et al
    Should we consider paranasal and chest computed tomography in severe asthma patients?
    Respir Med. 2020;169:106013.
    >> Share

  95. SHIRAI T, Furuuchi K, Fujiwara K, Nakamoto K, et al
    Impact of Aspergillus precipitating antibody test results on clinical outcomes of patients with Mycobacterium avium complex lung disease.
    Respir Med. 2020;166:105955.
    >> Share

  96. LARSSON-CALLERFELT AK, Muller C, Andersson-Sjoland A, Thiman L, et al
    VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Respir Med. 2020;166:105944.
    >> Share

  97. BEZERRA DE MENEZES M, Ponte EV, Bertagni Mingotti CF, Carvalho Pinto RM, et al
    Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Respir Med. 2020;166:105950.
    >> Share

  98. VOGELMEIER CF, Roman-Rodriguez M, Singh D, Han MK, et al
    Goals of COPD treatment: Focus on symptoms and exacerbations.
    Respir Med. 2020;166:105938.
    >> Share

    April 2020
  99. CANONICA GW, Malvezzi L, Blasi F, Paggiaro P, et al
    Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Respir Med. 2020;166:105947.
    >> Share

  100. BOUTOU AK, Daniil Z, Pitsiou G, Papakosta D, et al
    Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?
    Respir Med. 2020;167:105953.
    >> Share

  101. KOLTERMANN V, Friedrich FO, Fensterseifer AC, Ongaratto R, et al
    Cost-benefit impact of free asthma medication provision for the pediatric population.
    Respir Med. 2020;164:105915.
    >> Share

  102. DIAZ-GARCIA R, Flores-Ramirez G, Ramirez-Oseguera RT
    Effect of extrafine formulation of BDP/FF inhaler on asthma control, small airway function and airway inflammation among Mexican asthmatic patients. A retrospective analysis.
    Respir Med. 2020;165:105932.
    >> Share

  103. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    Corrigendum to "A review of the burden and management of mild asthma in adults - Implications for clinical practice" [Respir. Med. 152 (2019) 97-104].
    Respir Med. 2020;165:105872.
    >> Share

  104. FASTENAU A, van Schayck OC, Winkens B, Aretz K, et al
    Effectiveness of an exercise training programme COPD in primary care: A randomized controlled trial.
    Respir Med. 2020;165:105943.
    >> Share

    March 2020
  105. IMAM JS, Duarte AG
    Non-CF bronchiectasis: Orphan disease no longer.
    Respir Med. 2020;166:105940.
    >> Share

  106. VETRANO DL, Zucchelli A, Bianchini E, Marconi E, et al
    Patterns of oral corticosteroids use in primary care patients with severe asthma.
    Respir Med. 2020;166:105946.
    >> Share

  107. LAVORINI F, Bianco A, Blasi F, Braido F, et al
    What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
    Respir Med. 2020;166:105937.
    >> Share

  108. SCHNEEBERGER T, Jarosch I, Moll J, Gloeckl R, et al
    Increased asthma control after a 3-week inpatient pulmonary rehabilitation program.
    Respir Med. 2020;165:105930.
    >> Share

  109. ENGELKES M, de Ridder MA, Svensson E, Berencsi K, et al
    Multinational cohort study of mortality in patients with asthma and severe asthma.
    Respir Med. 2020;165:105919.
    >> Share

  110. RODRIGUEZ-AGUILAR M, Diaz de Leon-Martinez L, Gorocica-Rosete P, Padilla RP, et al
    Identification of breath-prints for the COPD detection associated with smoking and household air pollution by electronic nose.
    Respir Med. 2020;163:105901.
    >> Share

    February 2020
  111. CAZZOLA M, Matera MG
    The effect of doxofylline in asthma and COPD.
    Respir Med. 2020;164:105904.
    >> Share

  112. DE KEYSER HEH, Kaye L, Anderson WC, Gondalia R, et al
    Electronic medication monitors help determine adherence subgroups in asthma.
    Respir Med. 2020;164:105914.
    >> Share

  113. SEDEH FB, Von Bulow A, Backer V, Bodtger U, et al
    The impact of dysfunctional breathing on the level of asthma control in difficult asthma.
    Respir Med. 2020;163:105894.
    >> Share

  114. LANARIO JW, Hyland ME, Wei Y, Jones RC, et al
    Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.
    Respir Med. 2020;162:105870.
    >> Share

  115. MARC-MALOVRH M, Camlek L, Skrgat S, Kern I, et al
    Elevated eosinophils, IL5 and IL8 in induced sputum in asthma patients with accelerated FEV1 decline.
    Respir Med. 2020;162:105875.
    >> Share

  116. MINGOTTI C, Sarinho J, Stanigher K, Silva J, et al
    Evaluating the FEV1/FVC ratio in the lower range of normality as a marker of worse clinical outcomes in asthmatic subjects without airway obstruction.
    Respir Med. 2020;162:105880.
    >> Share

  117. JANSSON SA, Backman H, Andersson M, Telg G, et al
    Severe asthma is related to high societal costs and decreased health related quality of life.
    Respir Med. 2020;162:105860.
    >> Share

  118. WAN ES, Kantorowski A, Polak M, Kadri R, et al
    Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations.
    Respir Med. 2020;162:105878.
    >> Share

  119. ZHOU M, Tan KS, Guan WJ, Jiang LJ, et al
    Proteomics profiling of epithelium-derived exosomes from nasal polyps revealed signaling functions affecting cellular proliferation.
    Respir Med. 2020;162:105871.
    >> Share

    January 2020
  120. KIM C, Ko Y, Jung JY, Lee JS, et al
    Severe vitamin D deficiency is associated with emphysema progression in male patients with COPD.
    Respir Med. 2020;163:105890.
    >> Share

  121. MILGER K, Korn S, Buhl R, Hamelmann E, et al
    Age- and sex-dependent differences in patients with severe asthma included in the German Asthma Net cohort.
    Respir Med. 2020;162:105858.
    >> Share

  122. KORNMANN O, Mucsi J, Kolosa N, Bandelli L, et al
    Efficacy and safety of inhaled once-daily low-dose indacaterol acetate/mometasone furoate in patients with inadequately controlled asthma: Phase III randomised QUARTZ study findings.
    Respir Med. 2020;161:105809.
    >> Share

  123. MASSIERER D, Alsowayan W, Lima VP, Bourbeau J, et al
    Prognostic value of simple measures of physical function and muscle strength in COPD: A systematic review.
    Respir Med. 2020;161:105856.
    >> Share

  124. MEYS R, Sillen MJ, Franssen FME, Stoffels AAF, et al
    Impact of mild-to-moderate exacerbations on outcomes of neuromuscular electrical stimulation (NMES) in patients with COPD.
    Respir Med. 2020;161:105851.
    >> Share

  125. MAHLER DA
    The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease.
    Respir Med. 2020;161:105857.
    >> Share

  126. BALAMURUGAN S, Apte K, Singh BP, Deb AK, et al
    Device-handling study of a novel breath-actuated inhaler, Synchrobreathe(R), versus a pMDI.
    Respir Med. 2020;161:105707.
    >> Share

  127. MASARWEH K, Gur M, Leiba R, Bar-Yoseph R, et al
    Factors predicting length of stay in bronchiolitis.
    Respir Med. 2020;161:105824.
    >> Share

  128. PROULX F, Laberge S, Macovoz N, Tse SM, et al
    Predictive factors for a shortened methacholine challenge protocol in children.
    Respir Med. 2020;161:105823.
    >> Share

    December 2019
  129. BUHL R, Heaney LG, Loefroth E, Larbig M, et al
    One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta2-agonist in UK primary care settings.
    Respir Med. 2019;162:105859.
    >> Share

    November 2019
  130. CRUZ AA, Riley JH, Bansal AT, Ponte EV, et al
    Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status.
    Respir Med. 2019;161:105817.
    >> Share

  131. MATUCCI A, Maggi E, Vultaggio A
    Eosinophils, the IL-5/IL-5Ralpha axis, and the biologic effects of benralizumab in severe asthma.
    Respir Med. 2019;160:105819.
    >> Share

  132. FRANCONERI A, Marasco E, Dore R, Codullo V, et al
    Pulmonary emphysema not combined with lung fibrosis in systemic sclerosis.
    Respir Med. 2019;160:105816.
    >> Share

  133. DE JONG CC, Mozun R
    The reference standard in diagnostic studies on childhood asthma.
    Respir Med. 2019 Nov 6:105812. doi: 10.1016/j.rmed.2019.105812.
    >> Share

  134. MANON-JENSEN T, Langholm LL, Ronnow SR, Karsdal MA, et al
    End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort.
    Respir Med. 2019;160:105814.
    >> Share

  135. ALBERS FC, Licskai C, Chanez P, Bratton DJ, et al
    Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma.
    Respir Med. 2019;159:105806.
    >> Share

  136. ZACCAGNINI M, Esquinas AM, Karim HMR
    In response to Galindo-Filho et al. A mesh nebulizer is more effective than jet nebulizer during noninvasive ventilation of COPD subjects: A few practical points.
    Respir Med. 2019;160:105754.
    >> Share

  137. BOUTOU AK, Papathanassiou M, Chloros A
    Bone mineral density and associated fractures in COPD patients: The role of inflammation and pulmonary rehabilitation.
    Respir Med. 2019;160:105708.
    >> Share

    October 2019
  138. CAMPO P, Soto Campos G, Aparicio MB, Jorge AM, et al
    Severe asthma phenotypes in patients controlled with omalizumab: A real-world study.
    Respir Med. 2019;159:105804.
    >> Share

  139. LABABIDI HM, AlSowayigh OM, BinHowemel SF, AlReshaid KM, et al
    Refractory asthma phenotyping based on immunoglobulin E levels and eosinophilic counts: A real life study.
    Respir Med. 2019;158:55-58.
    >> Share

  140. TEMAM S, Chanoine S, Bedard A, Dumas O, et al
    Low socioeconomic position and neighborhood deprivation are associated with uncontrolled asthma in elderly.
    Respir Med. 2019;158:70-77.
    >> Share

    September 2019
  141. CASALE TB, Aalbers R, Bleecker ER, Meltzer EO, et al
    Tiotropium Respimat(R) add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics.
    Respir Med. 2019;158:97-109.
    >> Share

  142. SNELL N, Gibson J, Jarrold I, Quint JK, et al
    Epidemiology of bronchiectasis in the UK: Findings from the British lung foundation's 'Respiratory health of the nation' project.
    Respir Med. 2019;158:21-23.
    >> Share

  143. LIU BC, Huang TX, Yang D, Yang L, et al
    Asthma-associated bronchiectasis: More attention needed!
    Respir Med. 2019 Sep 12. pii: S0954-6111(19)30289.
    >> Share

    August 2019
  144. TAY TR, Choo XN, Yii A, Chung KF, et al
    Asthma phenotypes in a multi-ethnic Asian cohort.
    Respir Med. 2019;157:42-48.
    >> Share

  145. GROSBOIS JM, Coquart J, Fry S, Le Rouzic O, et al
    Long-term effect of home-based pulmonary rehabilitation in severe asthma.
    Respir Med. 2019;157:36-41.
    >> Share

  146. KESSLER A, Kragl U, Glass A, Schmidt S, et al
    Exhaled nitric oxide can't replace the methacholine challenge in suspected pediatric asthma.
    Respir Med. 2019;157:21-25.
    >> Share

  147. OKONKWO CS, Davis BE, Blais CM, Cockcroft DW, et al
    Short-term effect of once-daily fluticasone furoate on methacholine-induced bronchoconstriction in mild asthmatics.
    Respir Med. 2019;156:53-57.
    >> Share

  148. CAZZOLA M, Rogliani P, Matera MG
    Ultra-LABAs for the treatment of asthma.
    Respir Med. 2019;156:47-52.
    >> Share

    July 2019
  149. ELSHEIKH MS, Mohamed NH, Alsharkawy AAA
    Improvement of asthma control after laser acupuncture and its impact on exhaled 8-isoprostane as an oxidative biomarker in chronic bronchial asthma.
    Respir Med. 2019;156:15-19.
    >> Share

  150. HISINGER-MOLKANEN H, Pallasaho P, Haahtela T, Lindqvist A, et al
    The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.
    Respir Med. 2019;155:121-126.
    >> Share

  151. MOORE LE, Kapoor K, Byers BW, Brotto AR, et al
    Acute effects of salbutamol on systemic vascular function in people with asthma.
    Respir Med. 2019;155:133-140.
    >> Share

  152. FELDMAN LY, Zhu J, To T
    Estimating age-specific influenza-associated asthma morbidity in Ontario, Canada.
    Respir Med. 2019;155:104-112.
    >> Share

  153. ALVES AM, Marques de Mello L, Lima Matos AS, Cruz AA, et al
    Severe asthma: Comparison of different classifications of severity and control.
    Respir Med. 2019;156:1-7.
    >> Share

  154. VISSER SK, Bye PTP, Fox GJ, Burr LD, et al
    Australian adults with bronchiectasis: The first report from the Australian Bronchiectasis Registry.
    Respir Med. 2019;155:97-103.
    >> Share

  155. KUO CR, Spears M, Haughney J, Smith A, et al
    Scottish consensus statement on the role of FeNO in adult asthma.
    Respir Med. 2019;155:54-57.
    >> Share

  156. GRAHAM LM, Kerstjens HAM, Vogelberg C, Hamelmann E, et al
    Safety of tiotropium Respimat((R)) in black or African-American patients with symptomatic asthma.
    Respir Med. 2019;155:58-60.
    >> Share

    June 2019
  157. GROSSO A, Pesce G, Marcon A, Piloni D, et al
    Depression is associated with poor control of symptoms in asthma and rhinitis: A population-based study.
    Respir Med. 2019;155:6-12.
    >> Share

  158. DIMITROVA D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, et al
    Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.
    Respir Med. 2019;154:144-154.
    >> Share

  159. CORDOVA-RIVERA L, Gibson PG, Gardiner PA, Hiles SA, et al
    Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
    Respir Med. 2019;154:93-101.
    >> Share

  160. MANSFIELD L, Bernstein JA
    Tiotropium in asthma: From bench to bedside.
    Respir Med. 2019;154:47-55.
    >> Share

  161. OCAL S, Portakal O, Ocal A, Demir AU, et al
    Corrigendum to "Factors associated with pulmonary hypertension and long-term survival in bronchiectasis subjects" [Respir. Med. (2016) 119109-114].
    Respir Med. 2019 Jun 11. pii: S0954-6111(19)30165.
    >> Share

  162. ALCARAZ-SERRANO V, Fernandez-Barat L, Scioscia G, Llorens-Llacuna J, et al
    Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis.
    Respir Med. 2019;154:40-46.
    >> Share

  163. HUMBERT M, Albers FC, Bratton DJ, Yancey SW, et al
    Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.
    Respir Med. 2019;154:69-75.
    >> Share

  164. HONKAMAKI J, Hisinger-Molkanen H, Ilmarinen P, Piirila P, et al
    Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood.
    Respir Med. 2019;154:56-62.
    >> Share

  165. MULGIRIGAMA A, Barnes N, Fletcher M, Pedersen S, et al
    A review of the burden and management of mild asthma in adults - Implications for clinical practice.
    Respir Med. 2019;152:97-104.
    >> Share

  166. GRAFF S, Demarche S, Henket M, Paulus V, et al
    Increase in blood eosinophils during follow-up is associated with lung function decline in adult asthma.
    Respir Med. 2019;152:60-66.
    >> Share

  167. MANISCALCO M, Calabrese C, D'Amato M, Guida P, et al
    Association between exhaled nitric oxide and nasal polyposis in severe asthma.
    Respir Med. 2019;152:20-24.
    >> Share

  168. MANTYLA J, Mazur W, Torola T, Bergman P, et al
    Asthma as aetiology of bronchiectasis in Finland.
    Respir Med. 2019;152:105-111.
    >> Share

  169. TYRAK KE, Kuprys-Lipinska I, Czarnobilska E, Jakiela B, et al
    Sputum biomarkers during aspirin desensitization in nonsteroidal anti-inflammatory drugs exacerbated respiratory disease.
    Respir Med. 2019;152:51-59.
    >> Share

    May 2019
  170. MONTALBANO L, Ferrante G, Cilluffo G, Gentile M, et al
    Targeting quality of life in asthmatic children: The MyTEP pilot randomized trial.
    Respir Med. 2019;153:14-19.
    >> Share

  171. MATERA MG, Calzetta L, Rogliani P, Cazzola M, et al
    Monoclonal antibodies for severe asthma: Pharmacokinetic profiles.
    Respir Med. 2019;153:3-13.
    >> Share

  172. KOSKELA HO, Latti AM, Pekkanen J
    Subfreezing air as a cough trigger and multiple triggers are strongly associated with the presence of asthma in chronic cough.
    Respir Med. 2019;153:26-30.
    >> Share

  173. BAI C, Jiang D, Wang L, Xue F, et al
    A high blood eosinophil count may be a risk factor for incident asthma in population at risk.
    Respir Med. 2019;151:59-65.
    >> Share

  174. PEREZ DE LLANO L, Martinez-Moragon E, Plaza Moral V, Trisan Alonso A, et al
    Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
    Respir Med. 2019;151:49-54.
    >> Share

  175. CAZZOLA M, Rogliani P, Calzetta L, Matera MG, et al
    Bronchodilators in subjects with asthma-related comorbidities.
    Respir Med. 2019;151:43-48.
    >> Share

  176. KERWIN EM, Hickey L, Small CJ
    Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
    Respir Med. 2019;151:35-42.
    >> Share

  177. YANCEY SW, Bradford ES, Keene ON
    Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of >/=150-300cells/muL.
    Respir Med. 2019;151:139-141.
    >> Share

  178. DIEL R, Ewig S, Blaas S, Jacob C, et al
    Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
    Respir Med. 2019;151:121-127.
    >> Share

  179. LICARI A, Brambilla I, Sacchi L, Marseglia G, et al
    Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Respir Med. 2019;151:118-120.
    >> Share

  180. DOMVRI K, Porpodis K, Tzimagiorgis G, Chatzopoulou F, et al
    Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation.
    Respir Med. 2019;151:102-110.
    >> Share

  181. MOON SM, Jhun BW, Baek SY, Kim S, et al
    Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Respir Med. 2019;151:1-7.
    >> Share

  182. ERIKSSON G, Nolte H, Ljorring C, Riis B, et al
    Comparison of the novel CompEx asthma exacerbation endpoint to the ATS/ERS adapted moderate/severe asthma exacerbation definition used in the MITRA trial.
    Respir Med. 2019;153:1-2.
    >> Share

    April 2019
  183. WANG M, Liu M, Wang C, Xiao Y, et al
    Association between vitamin D status and asthma control: A meta-analysis of randomized trials.
    Respir Med. 2019;150:85-94.
    >> Share

  184. LEE E, Shim JY, Kim HY, Suh DI, et al
    Clinical characteristics and etiologies of bronchiectasis in Korean children: A multicenter retrospective study.
    Respir Med. 2019;150:8-14.
    >> Share

  185. SEGURA-MEDINA P, Vargas MH, Aguilar-Romero JM, Arreola-Ramirez JL, et al
    Mold burden in house dust and its relationship with asthma control.
    Respir Med. 2019;150:74-80.
    >> Share

  186. TARIQ K, Schofield JPR, Nicholas BL, Burg D, et al
    Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma.
    Respir Med. 2019;150:66-73.
    >> Share

  187. KATSAOUNOU P, Buhl R, Brusselle G, Pfister P, et al
    Omalizumab as alternative to chronic use of oral corticosteroids in severe asthma.
    Respir Med. 2019;150:51-62.
    >> Share

  188. KWON BS, Lee JH, Koh Y, Kim WS, et al
    The natural history of non-cavitary nodular bronchiectatic Mycobacterium avium complex lung disease.
    Respir Med. 2019;150:45-50.
    >> Share

  189. KWON JW, Jung H, Kim SH, Chang YS, et al
    High ACT score is not sufficient to reduce the risk of asthma exacerbations in asthma with low lung function.
    Respir Med. 2019;150:38-44.
    >> Share

  190. ICHIKAWA T, Panariti A, Audusseau S, Mogas AK, et al
    Effect of bronchial thermoplasty on structural changes and inflammatory mediators in the airways of subjects with severe asthma.
    Respir Med. 2019;150:165-172.
    >> Share

  191. AARAB R, Vijverberg SJH, Prins M, Snijder MB, et al
    Prevalence of and factors associated with adult-onset asthma in different ethnic groups: The HELIUS study.
    Respir Med. 2019;150:113-119.
    >> Share

  192. AWERBACH JD, Stackhouse KA, Lee J, Dahhan T, et al
    Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance.
    Respir Med. 2019;150:126-130.
    >> Share

    March 2019
  193. YANG D, Huang T, Liu B, Liu C, et al
    To the editor: Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?
    Respir Med. 2019 Mar 16. pii: S0954-6111(19)30079.
    >> Share

  194. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    >> Share

  195. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    >> Share

  196. FERRI S, Crimi C, Heffler E, Campisi R, et al
    Vitamin D and disease severity in bronchiectasis.
    Respir Med. 2019;148:1-5.
    >> Share

  197. KURUVILLA ME, Vanijcharoenkarn K, Shih JA, Lee FE, et al
    Epidemiology and risk factors for asthma.
    Respir Med. 2019;149:16-22.
    >> Share

  198. ALVES JUNIOR SF, Zanetti G, Alves de Melo AS, Souza AS Jr, et al
    Neurofibromatosis type 1: State-of-the-art review with emphasis on pulmonary involvement.
    Respir Med. 2019;149:9-15.
    >> Share

  199. MOY ML, Harrington KF, Sternberg AL, Krishnan JA, et al
    Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial.
    Respir Med. 2019;149:52-58.
    >> Share

  200. STOLK J, Aggarwal N, Hochnadel I, Wrenger S, et al
    Blood monocyte profiles in COPD patients with PiMM and PiZZ alpha1-antitrypsin.
    Respir Med. 2019;148:60-62.
    >> Share

  201. CEN J, Ma H, Chen Z, Weng L, et al
    Monitoring peak expiratory flow could predict COPD exacerbations: A prospective observational study.
    Respir Med. 2019;148:43-48.
    >> Share

  202. KAMEYAMA N, Chubachi S, Sasaki M, Tsutsumi A, et al
    Predictive and modifying factors of bone mineral density decline in patients with COPD.
    Respir Med. 2019;148:13-23.
    >> Share

    February 2019
  203. KOSSE RC, Bouvy ML, de Vries TW, Koster ES, et al
    Effect of a mHealth intervention on adherence in adolescents with asthma: A randomized controlled trial.
    Respir Med. 2019 Feb 16. pii: S0954-6111(19)30045.
    >> Share

  204. JEMINIWA R, Hohmann L, Qian J, Garza K, et al
    Impact of eHealth on medication adherence among patients with asthma: A systematic review and meta-analysis.
    Respir Med. 2019 Feb 15. pii: S0954-6111(19)30047.
    >> Share

  205. TAPONEN S, Uitti J, Karvala K, Luukkonen R, et al
    Asthma diagnosed in late adulthood is linked to work disability and poor employment status.
    Respir Med. 2019;147:76-78.
    >> Share

  206. CIOLKOWSKI J, Emeryk A, Hydzik P, Emeryk-Maksymiuk J, et al
    Eosinophilic airway inflammation is a main feature of unstable asthma in adolescents.
    Respir Med. 2019;147:7-12.
    >> Share

  207. BJERMER L, Eriksson G, Radner F, Peterson S, et al
    Time to onset of improvements in Quality of Life from Temperature-controlled Laminar Airflow (TLA) in severe allergic asthma.
    Respir Med. 2019;147:19-25.
    >> Share

  208. BAKERLY ND, Woodcock A, Collier S, Leather DA, et al
    Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.
    Respir Med. 2019;147:58-65.
    >> Share

  209. PAPI A, Zheng J, Criner GJ, Fabbri LM, et al
    Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: A post-hoc analysis of the PANTHEON study.
    Respir Med. 2019;147:37-43.
    >> Share

  210. FORMIGA MF, Vital I, Urdaneta G, Campos MA, et al
    Beyond inspiratory muscle strength: Clinical utility of single-breath work capacity assessment in veterans with COPD.
    Respir Med. 2019;147:13-18.
    >> Share

  211. KELLER K, Hobohm L, Munzel T, Ostad MA, et al
    Impact of chronic obstructive pulmonary disease on the outcomes of patients with peripheral artery disease.
    Respir Med. 2019;147:1-6.
    >> Share

    January 2019
  212. KATSOULIS K, Ismailos G, Kipourou M, Kostikas K, et al
    Microbiota and asthma: Clinical implications.
    Respir Med. 2019;146:28-35.
    >> Share

  213. ALSUMRAIN M, De Giacomi F, Nasim F, Koo CW, et al
    Combined pulmonary fibrosis and emphysema as a clinicoradiologic entity: Characterization of presenting lung fibrosis and implications for survival.
    Respir Med. 2019;146:106-112.
    >> Share

  214. BALDACCI S, Simoni M, Maio S, Angino A, et al
    Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice.
    Respir Med. 2019;146:10-17.
    >> Share

  215. CONDE DIEZ S, Viejo Casas A, Garcia Rivero JL, Lopez Caro JC, et al
    Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO).
    Respir Med. 2019;146:96-105.
    >> Share

  216. REIJNDERS T, Schuler M, Wittmann M, Jelusic D, et al
    The impact of disease-specific fears on outcome measures of pulmonary rehabilitation in patients with COPD.
    Respir Med. 2019;146:87-95.
    >> Share

  217. YASUI H, Inui N, Karayama M, Mori K, et al
    Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
    Respir Med. 2019;146:76-80.
    >> Share

  218. CHARBONNIER JP, Pompe E, Moore C, Humphries S, et al
    Airway wall thickening on CT: Relation to smoking status and severity of COPD.
    Respir Med. 2019;146:36-41.
    >> Share

  219. HILL K, Ng C, Wootton SL, McKeough ZJ, et al
    The minimal detectable difference for endurance shuttle walk test performance in people with COPD on completion of a program of high-intensity ground-based walking.
    Respir Med. 2019;146:18-22.
    >> Share

  220. KYOMOTO Y, Kanazawa H, Tochino Y, Watanabe T, et al
    Possible role of airway microvascular permeability on airway obstruction in patients with chronic obstructive pulmonary disease.
    Respir Med. 2019;146:137-141.
    >> Share

  221. CARSIN AE, Fuertes E, Schaffner E, Jarvis D, et al
    Restrictive spirometry pattern is associated with low physical activity levels. A population based international study.
    Respir Med. 2019;146:116-123.
    >> Share

  222. PAINE NJ, Bacon SL, Bourbeau J, Tan WC, et al
    Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.
    Respir Med. 2019;146:1-9.
    >> Share

    December 2018
  223. LIMA-MATOS A, Ponte EV, de Jesus JPV, Almeida PCA, et al
    Eosinophilic asthma, according to a blood eosinophil criterion, is associated with disease severity and lack of control among underprivileged urban Brazilians.
    Respir Med. 2018;145:95-100.
    >> Share

  224. MATTHES S, Stadler J, Barton J, Leuschner G, et al
    Asthma features in severe COPD: Identifying treatable traits.
    Respir Med. 2018;145:89-94.
    >> Share

  225. ZENG J, Chen Z, Hu Y, Hu Q, et al
    Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide.
    Respir Med. 2018;145:8-13.
    >> Share

  226. BALTIERI L, Cazzo E, de Souza AL, Alegre SM, et al
    Influence of weight loss on pulmonary function and levels of adipokines among asthmatic individuals with obesity: One-year follow-up.
    Respir Med. 2018;145:48-56.
    >> Share

  227. VON BULOW A, Backer V, Bodtger U, Soes-Petersen NU, et al
    Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.
    Respir Med. 2018;145:41-47.
    >> Share

  228. HOSSEINI SA, Zilaee M, Shoushtari MH, Ghasemi Dehcheshmeh M, et al
    An evaluation of the effect of saffron supplementation on the antibody titer to heat-shock protein (HSP) 70, hsCRP and spirometry test in patients with mild and moderate persistent allergic asthma: A triple-blind, randomized placebo-controlled trial.
    Respir Med. 2018;145:28-34.
    >> Share

  229. PEREIRA AA, Pollard SL, Locke R, Romero K, et al
    Association between exhaled carbon monoxide and asthma outcomes in Peruvian children.
    Respir Med. 2018;145:212-216.
    >> Share

  230. AJALA O, Zhang Y, Gupta A, Bon J, et al
    Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease.
    Respir Med. 2018;145:21-27.
    >> Share

  231. O'NEILL K, Lakshmipathy GR, Ferguson K, Cosgrove D, et al
    Quality control for multiple breath washout tests in multicentre bronchiectasis studies: Experiences from the BRONCH-UK clinimetrics study.
    Respir Med. 2018;145:206-211.
    >> Share

  232. RADOVANOVIC D, Santus P, Blasi F, Sotgiu G, et al
    A comprehensive approach to lung function in bronchiectasis.
    Respir Med. 2018;145:120-129.
    >> Share

  233. MAO S, Wu L, Shi W
    Association between trace elements levels and asthma susceptibility.
    Respir Med. 2018;145:110-119.
    >> Share

    November 2018
  234. NGUYEN TS, Nguyen TLH, Pham TTV, Cao TBT, et al
    Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling - A simulated patient study.
    Respir Med. 2018;144:50-60.
    >> Share

  235. NORDON C, Grimaldi-Bensouda L, Pribil C, Nachbaur G, et al
    Clinical and economic burden of severe asthma: A French cohort study.
    Respir Med. 2018;144:42-49.
    >> Share

  236. JEPPEGAARD M, Veidal S, Sverrild A, Backer V, et al
    Validation of ATS clinical practice guideline cut-points for FeNO in asthma.
    Respir Med. 2018;144:22-29.
    >> Share

    October 2018
  237. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    >> Share

  238. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    >> Share

  239. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    >> Share

  240. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    >> Share

  241. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    >> Share

  242. BIANCHI L, Bezzi M, Berlendis M, Marino S, et al
    Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema.
    Respir Med. 2018;143:116-122.
    >> Share

  243. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    >> Share

    September 2018
  244. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.
    >> Share

  245. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    >> Share

  246. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    >> Share

  247. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    >> Share

  248. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    >> Share

  249. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    >> Share

  250. DE BENEDETTO F, Pastorelli R, Ferrario M, de Blasio F, et al
    Supplementation with Qter((R)) and Creatine improves functional performance in COPD patients on long term oxygen therapy.
    Respir Med. 2018;142:86-93.
    >> Share

  251. SORIANO JB, Hahsler M, Soriano C, Martinez C, et al
    Temporal transitions in COPD severity stages within the GOLD 2017 classification system.
    Respir Med. 2018;142:81-85.
    >> Share

  252. BOGART M, Stanford RH, Reinsch T, Hull M, et al
    Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study.
    Respir Med. 2018;142:73-80.
    >> Share

  253. VAES AW, Spruit MA, Theunis J, Wouters EFM, et al
    Peripheral endothelial function is positively associated with maximal aerobic capacity in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;142:41-47.
    >> Share

    August 2018
  254. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    >> Share

  255. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    >> Share

  256. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    >> Share

  257. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    >> Share

  258. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    >> Share

  259. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    >> Share

  260. MCDONNELL MJ, O'Toole D, Ward C, Pearson JP, et al
    A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.
    Respir Med. 2018;141:132-143.
    >> Share

  261. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    >> Share

  262. SCHULER M, Wittmann M, Faller H, Schultz K, et al
    Including changes in dyspnea after inpatient rehabilitation improves prediction models of exacerbations in COPD.
    Respir Med. 2018;141:87-93.
    >> Share

  263. KOUIJZER M, Brusse-Keizer M, Bode C
    COPD-related fatigue: Impact on daily life and treatment opportunities from the patient's perspective.
    Respir Med. 2018;141:47-51.
    >> Share

  264. OHAR JA, Loh CH, Lenoir KM, Wells BJ, et al
    A comprehensive care plan that reduces readmissions after acute exacerbations of COPD.
    Respir Med. 2018;141:20-25.
    >> Share

  265. DOMENECH A, Munoz-Montiel A, Garcia-Casares N, Rioja J, et al
    High risk of subclinical atherosclerosis in COPD exacerbator phenotype.
    Respir Med. 2018;141:165-171.
    >> Share

  266. KAWAMOTO T, Kanazawa H, Tochino Y, Kawaguchi T, et al
    Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
    Respir Med. 2018;141:159-164.
    >> Share

  267. FANER R, Noell G, Badia JR, Lopez-Giraldo A, et al
    Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort.
    Respir Med. 2018;141:14-19.
    >> Share

  268. GOOD JT JR, Rollins DR, Kolakowski CA, Stevens AD, et al
    New insights in the diagnosis of chronic refractory cough.
    Respir Med. 2018;141:103-110.
    >> Share

  269. SCHISSLER AJ, Celli BR
    Prevalence of paradoxical bronchoconstriction after inhaled albuterol.
    Respir Med. 2018;141:100-102.
    >> Share

  270. SIEVI NA, Brack T, Brutsche MH, Frey M, et al
    Physical activity declines in COPD while exercise capacity remains stable: A longitudinal study over 5 years.
    Respir Med. 2018;141:1-6.
    >> Share

    July 2018
  271. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    >> Share

  272. CHUNG WS, Lin CL
    Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.
    Respir Med. 2018;140:6-10.
    >> Share

  273. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    >> Share

  274. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    >> Share

  275. LABAKI WW, Xia M, Murray S, Curtis JL, et al
    NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Respir Med. 2018;140:87-93.
    >> Share

  276. WAN ES, Kantorowski A, Homsy D, Kadri R, et al
    Self-reported task-oriented physical activity: A comparison with objective daily step count in COPD.
    Respir Med. 2018;140:63-70.
    >> Share

  277. HENRIKSEN DP, Davidsen JR, Laursen CB
    Nationwide use of theophylline among adults-A 20-year Danish drug utilisation study.
    Respir Med. 2018;140:57-62.
    >> Share

  278. JUNG IY, Jeong SJ, Lee KM, Ahn JY, et al
    Risk factors for mortality in patients with Pseudomonas aeruginosa pneumonia: Clinical impact of mucA gene mutation.
    Respir Med. 2018;140:27-31.
    >> Share

  279. BEHROOZ L, Balekian DS, Faridi MK, Espinola JA, et al
    Prenatal and postnatal tobacco smoke exposure and risk of severe bronchiolitis during infancy.
    Respir Med. 2018;140:21-26.
    >> Share

  280. SIAFAKAS N, Bizymi N, Mathioudakis A, Corlateanu A, et al
    EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD).
    Respir Med. 2018;140:127-131.
    >> Share

  281. HYLDGAARD C, Bendstrup E, Pedersen AB, Ulrichsen SP, et al
    Increased mortality among patients with rheumatoid arthritis and COPD: A population-based study.
    Respir Med. 2018;140:101-107.
    >> Share

    June 2018
  282. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    >> Share

  283. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    >> Share

  284. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    >> Share

  285. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    >> Share

  286. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    >> Share

  287. HAHN B, Hull M, Blauer-Peterson C, Buikema AR, et al
    Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
    Respir Med. 2018;139:65-71.
    >> Share

  288. FERRARI R, Caram LMO, Tanni SE, Godoy I, et al
    The relationship between Vitamin D status and exacerbation in COPD patients- a literature review.
    Respir Med. 2018;139:34-38.
    >> Share

  289. LIU S, Zhou Y, Liu S, Zou W, et al
    Clinical impact of the lower limit of normal of FEV1/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional data.
    Respir Med. 2018;139:27-33.
    >> Share

  290. GOVE K, Wilkinson T, Jack S, Ostridge K, et al
    Systematic review of evidence for relationships between physiological and CT indices of small airways and clinical outcomes in COPD.
    Respir Med. 2018;139:117-125.
    >> Share

  291. DESVEAUX L, Harrison SL, Gagnon JF, Goldstein RS, et al
    Effects of exercise training on cognition in chronic obstructive pulmonary disease: A systematic review.
    Respir Med. 2018;139:110-116.
    >> Share

  292. LIPWORTH BJ, Jabbal S
    What can we learn about COPD from impulse oscillometry?
    Respir Med. 2018;139:106-109.
    >> Share

    May 2018
  293. JACOB J, Odink A, Brun AL, Macaluso C, et al
    Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.
    Respir Med. 2018;138:95-101.
    >> Share

  294. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    >> Share

  295. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    >> Share

  296. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    >> Share

  297. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    >> Share

  298. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    >> Share

  299. MCNAMARA RJ, Houben-Wilke S, Franssen FME, Smid DE, et al
    Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:81-87.
    >> Share

  300. FAKIH F, Spangenthal S, Sigal B, Darken P, et al
    Randomized study of the effects of Aerochamber Plus((R)) Flow-Vu((R)) on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Respir Med. 2018;138:74-80.
    >> Share

  301. OLIVEIRA A, Rodrigues J, Marques A
    Enhancing our understanding of computerised adventitious respiratory sounds in different COPD phases and healthy people.
    Respir Med. 2018;138:57-63.
    >> Share

  302. BHATTA L, Leivseth L, Mai XM, Chen Y, et al
    Prevalence and trend of COPD from 1995-1997 to 2006-2008: The HUNT study, Norway.
    Respir Med. 2018;138:50-56.
    >> Share

  303. BRUSSELLE G, Pavord ID, Landis S, Pascoe S, et al
    Blood eosinophil levels as a biomarker in COPD.
    Respir Med. 2018;138:21-31.
    >> Share

  304. MORALES DR, Flynn R, Zhang J, Trucco E, et al
    External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches.
    Respir Med. 2018;138:150-155.
    >> Share

  305. NADERI N, Assayag D, Mostafavi-Pour-Manshadi SM, Kaddaha Z, et al
    Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease.
    Respir Med. 2018;138:129-136.
    >> Share

  306. CORDOBA-LANUS E, Cabrera-Lopez C, Cazorla-Rivero S, Rodriguez-Perez MC, et al
    Shorter telomeres in non-smoking patients with airflow limitation.
    Respir Med. 2018;138:123-128.
    >> Share

    April 2018
  307. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    >> Share

  308. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    >> Share

  309. SATIRER O, Mete Yesil A, Emiralioglu N, Tugcu GD, et al
    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
    Respir Med. 2018;137:35-39.
    >> Share

  310. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    >> Share

  311. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    >> Share

  312. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    >> Share

  313. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    >> Share

  314. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    >> Share

  315. VAN HIRTUM PV, Sprooten RTM, van Noord JA, van Vliet M, et al
    Long term survival after admission for COPD exacerbation: A comparison with the general population.
    Respir Med. 2018;137:77-82.
    >> Share

  316. VAZ FRAGOSO CA, Van Ness PH, Murphy TE, McAvay GJ, et al
    Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.
    Respir Med. 2018;137:40-47.
    >> Share

  317. LANGTON D, Wang W, Thien F, Plummer V, et al
    The acute effects of bronchial thermoplasty on FEV1.
    Respir Med. 2018;137:147-151.
    >> Share

  318. ALTER P, Watz H, Kahnert K, Pfeifer M, et al
    Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.
    Respir Med. 2018;137:14-22.
    >> Share

  319. CHEROT-KORNOBIS N, Hulo S, Giovannelli J, de Broucker V, et al
    Exhaled breath NOx levels in a middle-aged adults population-based study: reference values and association with the smoking status.
    Respir Med. 2018;137:134-140.
    >> Share

  320. CHEN YW, Coxson HO, Coupal TM, Lam S, et al
    The contribution of thoracic vertebral deformity and arthropathy to trunk pain in patients with chronic obstructive pulmonary disease (COPD).
    Respir Med. 2018;137:115-122.
    >> Share

  321. MILNER SC, Boruff JT, Beaurepaire C, Ahmed S, et al
    Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: A systematic scoping review.
    Respir Med. 2018;137:103-114.
    >> Share

  322. REITER J, Breuer A, Breuer O, Hashavya S, et al
    A quality improvement intervention to reduce emergency department radiography for bronchiolitis.
    Respir Med. 2018;137:1-5.
    >> Share

    March 2018
  323. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    >> Share

  324. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    >> Share

  325. ZELT JT, Jones JH, Hirai DM, King TJ, et al
    Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Respir Med. 2018;136:29-36.
    >> Share

  326. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    >> Share

  327. SUAREZ-CUARTIN G, Giner J, Merino JL, Rodrigo-Troyano A, et al
    Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Respir Med. 2018;136:111-117.
    >> Share

  328. KRIDIN K, Comaneshter D, Batat E, Cohen AD, et al
    COPD and lung cancer in patients with pemphigus- a population based study.
    Respir Med. 2018;136:93-97.
    >> Share

  329. MIRAVITLLES M, Sliwinski P, Rhee CK, Costello RW, et al
    Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.
    Respir Med. 2018;136:8-14.
    >> Share

  330. EPSTEIN D, Nasser R, Mashiach T, Azzam ZS, et al
    Increased red cell distribution width: A novel predictor of adverse outcome in patients hospitalized due to acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2018;136:1-7.
    >> Share

    February 2018
  331. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    >> Share

  332. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    >> Share

  333. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    >> Share

  334. RODRIGUEZ-JIMENEZ JC, Moreno-Paz FJ, Teran LM, Guani-Guerra E, et al
    Aspirin exacerbated respiratory disease: Current topics and trends.
    Respir Med. 2018;135:62-75.
    >> Share

  335. SIKJAER MG, Lokke A, Hilberg O
    The influence of psychiatric disorders on the course of lung cancer, chronic obstructive pulmonary disease and tuberculosis.
    Respir Med. 2018;135:35-41.
    >> Share

    Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices.
    Respir Med. 2018;135:12-14.
    >> Share

    January 2018
  337. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    >> Share

  338. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    >> Share

  339. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    >> Share

  340. GAO YH, Liu SX, Cui JJ, Wang LY, et al
    Subclinical atherosclerosis in adults with steady-state bronchiectasis: A case-control study.
    Respir Med. 2018;134:110-116.
    >> Share

  341. KAHNERT K, Alter P, Young D, Lucke T, et al
    The revised GOLD 2017 COPD categorization in relation to comorbidities.
    Respir Med. 2018;134:79-85.
    >> Share

  342. MIRAVITLLES M, Menezes A, Lopez Varela MV, Casas A, et al
    Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Respir Med. 2018;134:62-69.
    >> Share

  343. FERGUSON GT, Hickey AJ, Dwivedi S
    Co-suspension delivery technology in pressurized metered-dose inhalers for multi-drug dosing in the treatment of respiratory diseases.
    Respir Med. 2018;134:16-23.
    >> Share

  344. DE BLASIO F, Di Gregorio A, de Blasio F, Bianco A, et al
    Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables.
    Respir Med. 2018;134:1-5.
    >> Share

    December 2017
  345. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    >> Share

  346. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    >> Share

  347. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    >> Share

  348. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    >> Share

    November 2017
  349. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    >> Share

  350. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    >> Share

  351. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    >> Share

  352. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    >> Share

  353. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    >> Share

  354. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    >> Share

  355. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    >> Share

  356. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    >> Share

    October 2017
  357. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    >> Share

  358. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    >> Share

  359. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    >> Share

  360. AGGELOU K, Siafakas N
    Medical lung volume reduction for severe emphysema: A review.
    Respir Med. 2017;131:141-147.
    >> Share

  361. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    >> Share

  362. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    >> Share

    September 2017
  363. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    >> Share

  364. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    >> Share

  365. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    >> Share

  366. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    >> Share

  367. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    >> Share

    June 2017
  368. DI MARCO F, Terraneo S, Job S, Rinaldo RF, et al
    Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Respir Med. 2017;127:7-13.
    >> Share

  369. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    >> Share

  370. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    >> Share

  371. KONNO S, Makita H, Suzuki M, Shimizu K, et al
    Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Respir Med. 2017;127:14-20.
    >> Share

    May 2017
  372. GLOECKL R, Jarosch I, Bengsch U, Claus M, et al
    What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial.
    Respir Med. 2017;126:17-24.
    >> Share

  373. MESQUITA R, Meijer K, Pitta F, Azcuna H, et al
    Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD.
    Respir Med. 2017;126:122-129.
    >> Share

  374. HANANIA NA, Tashkin DP, Kerwin EM, Donohue JF, et al
    Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension Delivery Technology in patients with chronic obstructive pulmonary disease.
    Respir Med. 2017;126:105-115.
    >> Share

    April 2017
  375. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    >> Share

  376. BODINI R, Santus P, Di Marco F, Aliberti S, et al
    Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy.
    Respir Med. 2017;125:8-11.
    >> Share

  377. DI MARCO F, Santus P, Scichilone N, Solidoro P, et al
    Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Respir Med. 2017;125:49-56.
    >> Share

  378. D'URZO A, Rennard S, Kerwin E, Donohue JF, et al
    A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    Respir Med. 2017;125:39-48.
    >> Share

  379. SHIH YN, Chen YT, Chu H, Shih CJ, et al
    Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis.
    Respir Med. 2017;125:33-38.
    >> Share

  380. TOTTENBORG SS, Lange P, Thomsen RW, Nielsen H, et al
    Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Respir Med. 2017;125:19-23.
    >> Share

  381. HONG JY, Jung JY, Lee MG, Kim SK, et al
    Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data.
    Respir Med. 2017;125:12-18.
    >> Share

    March 2017
  382. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    >> Share

  383. KARDOS P, Vogelmeier C, Worth H, Buhl R, et al
    A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Respir Med. 2017;124:57-64.
    >> Share

    February 2017
  384. BOURBEAU J, Aaron SD, Barnes NC, Davis KJ, et al
    Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Respir Med. 2017;123:94-97.
    >> Share

  385. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    Chronic bronchitis in relation to hospitalization and mortality over three decades.
    Respir Med. 2017;123:87-93.
    >> Share

  386. SILER TM, Nagai A, Scott-Wilson CA, Midwinter DA, et al
    A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 mug versus once-daily vilanterol 25 mug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
    Respir Med. 2017;123:8-17.
    >> Share

  387. OYAMA Y, Enomoto N, Suzuki Y, Kono M, et al
    Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).
    Respir Med. 2017;123:63-70.
    >> Share

  388. POMPE E, Galban CJ, Ross BD, Koenderman L, et al
    Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.
    Respir Med. 2017;123:48-55.
    >> Share

  389. WANG LY, Zhu YN, Cui JJ, Yin KQ, et al
    Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2017;123:18-27.
    >> Share

  390. MELZER AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, et al
    Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.
    Respir Med. 2017;123:124-130.
    >> Share

  391. DELLWEG D, Reissig K, Hoehn E, Siemon K, et al
    Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.
    Respir Med. 2017;123:116-123.
    >> Share

    January 2017
  392. BUHL R, Magder S, Bothner U, Tetzlaff K, et al
    Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Respir Med. 2017;122:58-66.
    >> Share

  393. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    >> Share

  394. PAULIN FV, Zagatto AM, Chiappa GR, Muller PT, et al
    Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study.
    Respir Med. 2017;122:23-29.
    >> Share

  395. MUELLER S, Wilke T, Bechtel B, Punekar YS, et al
    Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Respir Med. 2017;122:1-11.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016